SCHEMBL31508140

SCHEMBL31508140

Nc1ccc(OC2CC2)cc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
PTGS1 P23219 1/20 0.43
PTGS2 P35354 1/20 0.43
FFAR4 Q5NUL3 2/20 0.39
ACACB O00763 3/20 0.37
ROCK1 Q13464 1/20 0.37
HRH3 Q9Y5N1 1/20 0.36
GPR119 Q8TDV5 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
CA5A P35218 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CA5B Q9Y2D0 1/20 0.36
PARP10 Q53GL7 1/20 0.36
SLC6A2 P23975 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22289350 0.93 PTGS1 (0.51) ALDH1A1PTGS1PTGS2FFAR4ROCK1
SCHEMBL12355278 0.92 PTGS1 (0.42) ALDH1A1PTGS1PTGS2FFAR4ACACB
SCHEMBL18824973 0.87 PTGS1 (0.41) ALDH1A1PTGS1PTGS2FFAR4ACACB
SCHEMBL4008887 0.86 ACSL1 (0.49) PTGS1PTGS2FFAR4
SCHEMBL16513840 0.85 HRH3 (0.50) PTGS1PTGS2ACACBHRH3GPR119
SCHEMBL12355288 0.85 PTGS1 (0.46) PTGS1PTGS2FFAR4ACACBHRH3
SCHEMBL12021829 0.84 ALDH1A1 (0.39) ALDH1A1PTGS1PTGS2ACACBHRH3
SCHEMBL1337890 0.82 DHODH (0.46) FFAR4SLC6A2SLC6A4SLC6A3
SCHEMBL24716435 0.82 PTGS1 (0.46) PTGS1PTGS2FFAR4ACACBHRH3
SCHEMBL2248030 0.81 LGMN (0.48) ALDH1A1PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12384773-B2 Thiazole compounds and methods of use thereof ARCUS BIOSCIENCES, INC. (US) 2025-08-12 US disclosed
WO-2025096979-A1 THIAZOLE COMPOUNDS AS KIT INHIBITORS AND METHODS OF USE THEREOF ARCUS BIOSCIENCES, INC. (US) 2025-05-08 WO disclosed
US-20250145606-A1 THIAZOLE COMPOUNDS AND METHODS OF USE THEREOF ARCUS BIOSCIENCES, INC. (US) 2025-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12384773-B2 Thiazole compounds and methods of use thereof TPMT, CYP11B2, ABAT ALDH1A1 198/4885PTGS1 1195/4885PTGS2 1296/4885
US-20250145606-A1 THIAZOLE COMPOUNDS AND METHODS OF USE THEREOF TPMT, CYP11B2, ABAT ALDH1A1 198/4885PTGS1 1195/4885PTGS2 1296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.